In the case report of Imaki et al., regarding a case of MODY caused by a novel heterozygous RFX6 mutation p.R652X, the patient presented, in addition to a reduced insulin and GIP response, a reduced glucagon-like peptide 1 (GLP-1) response. This evidence concerns the gene GCG and MODY.